Maccura Medical Instrument Co., Ltd.

Maccura Medical Instrument Co., Ltd. specializes in in vitro diagnostic (IVD) devices primarily used in laboratory settings. Their product line includes integrated systems like chemistry and immunoassay analyzers, standalone analyzers such as automatic hematology analyzers and urine analyzers, and specialized tools like real-time PCR systems and chemiluminescence analyzers. These devices automate key diagnostic processes, including blood chemistry, hematology, nucleic acid extraction, and coagulation testing, to improve efficiency and accuracy in clinical testing.

Maccura Medical Instrument Co., Ltd. is based in China. While the company’s location influences its regulatory compliance framework—such as adherence to Chinese medical device standards—the specific regulatory status of its devices depends on individual authorizations in markets like the EU. For example, some of its devices are listed in the EU’s eudamed registry, indicating they meet EU regulatory requirements for in vitro diagnostics, though this does not apply globally.

Maccura’s devices are listed in the EU’s eudamed registry, which is a public database for in vitro diagnostic (IVD) medical devices authorized under EU regulations. Listing in eudamed confirms that these devices have undergone the necessary conformity assessment procedures (e.g., CE marking) to demonstrate compliance with EU IVD Directive or IVDR requirements. This transparency helps healthcare professionals, regulators, and authorities verify the device’s authorized status in the EU market.

Maccura’s devices fall under three regulatory classifications: Class A (low-risk devices with minimal intervention), Class B (moderate-risk devices requiring additional validation), and IVD General (a category for in vitro diagnostics that may include both low- and moderate-risk products). Classification determines the regulatory pathway for authorization, such as self-certification for Class A or more rigorous scrutiny for higher-risk devices like certain IVD General analyzers, ensuring appropriate oversight based on potential patient risk.